These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

423 related articles for article (PubMed ID: 27052803)

  • 1. Lentivirus pre-packed with Cas9 protein for safer gene editing.
    Choi JG; Dang Y; Abraham S; Ma H; Zhang J; Guo H; Cai Y; Mikkelsen JG; Wu H; Shankar P; Manjunath N
    Gene Ther; 2016 Jul; 23(7):627-33. PubMed ID: 27052803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
    Soriano V
    AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CCR5 gene disruption via lentiviral vectors expressing Cas9 and single guided RNA renders cells resistant to HIV-1 infection.
    Wang W; Ye C; Liu J; Zhang D; Kimata JT; Zhou P
    PLoS One; 2014; 9(12):e115987. PubMed ID: 25541967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In Vivo Excision of HIV-1 Provirus by saCas9 and Multiplex Single-Guide RNAs in Animal Models.
    Yin C; Zhang T; Qu X; Zhang Y; Putatunda R; Xiao X; Li F; Xiao W; Zhao H; Dai S; Qin X; Mo X; Young WB; Khalili K; Hu W
    Mol Ther; 2017 May; 25(5):1168-1186. PubMed ID: 28366764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell-Penetrating Peptide-Mediated Delivery of Cas9 Protein and Guide RNA for Genome Editing.
    Suresh B; Ramakrishna S; Kim H
    Methods Mol Biol; 2017; 1507():81-94. PubMed ID: 27832534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and Assembly of CRISPR/Cas9 Lentiviral and rAAV Vectors for Targeted Genome Editing.
    Sandoval IM; Collier TJ; Manfredsson FP
    Methods Mol Biol; 2019; 1937():29-45. PubMed ID: 30706388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficient viral delivery of Cas9 into human safe harbor.
    Hayashi H; Kubo Y; Izumida M; Matsuyama T
    Sci Rep; 2020 Dec; 10(1):21474. PubMed ID: 33293588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and Evaluation of Guide RNA Transcripts with a 3'-Terminal HDV Ribozyme to Enhance CRISPR-Based Gene Inactivation.
    Berkhout B; Gao Z; Herrera-Carrillo E
    Methods Mol Biol; 2021; 2167():205-224. PubMed ID: 32712922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficient Cas9 multiplex editing using unspaced sgRNA arrays engineering in a Potato virus X vector.
    Uranga M; Aragonés V; Selma S; Vázquez-Vilar M; Orzáez D; Daròs JA
    Plant J; 2021 Apr; 106(2):555-565. PubMed ID: 33484202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CRISPR-Cas9 system-driven site-specific selection pressure on Herpes simplex virus genomes.
    Li Z; Bi Y; Xiao H; Sun L; Ren Y; Li Y; Chen C; Cun W
    Virus Res; 2018 Jan; 244():286-295. PubMed ID: 28279800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [CRISPR/CAS9, the King of Genome Editing Tools].
    Bannikov AV; Lavrov AV
    Mol Biol (Mosk); 2017; 51(4):582-594. PubMed ID: 28900076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A lentivirus-based system for Cas9/gRNA expression and subsequent removal by Cre-mediated recombination.
    Carpenter MA; Law EK; Serebrenik A; Brown WL; Harris RS
    Methods; 2019 Mar; 156():79-84. PubMed ID: 30578845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Production and Validation of Lentiviral Vectors for CRISPR/Cas9 Delivery.
    Ryø LB; Thomsen EA; Mikkelsen JG
    Methods Mol Biol; 2019; 1961():93-109. PubMed ID: 30912042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Doxycycline-Dependent Self-Inactivation of CRISPR-Cas9 to Temporally Regulate On- and Off-Target Editing.
    Kelkar A; Zhu Y; Groth T; Stolfa G; Stablewski AB; Singhi N; Nemeth M; Neelamegham S
    Mol Ther; 2020 Jan; 28(1):29-41. PubMed ID: 31601489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CRISPR/Cas9 Ablation of Integrated HIV-1 Accumulates Proviral DNA Circles with Reformed Long Terminal Repeats.
    Lai M; Maori E; Quaranta P; Matteoli G; Maggi F; Sgarbanti M; Crucitta S; Pacini S; Turriziani O; Antonelli G; Heeney JL; Freer G; Pistello M
    J Virol; 2021 Nov; 95(23):e0135821. PubMed ID: 34549986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delivering Cas9/sgRNA ribonucleoprotein (RNP) by lentiviral capsid-based bionanoparticles for efficient 'hit-and-run' genome editing.
    Lyu P; Javidi-Parsijani P; Atala A; Lu B
    Nucleic Acids Res; 2019 Sep; 47(17):e99. PubMed ID: 31299082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased Efficiency for Biallelic Mutations of the
    Lin D; Scheller SH; Robinson MM; Izadpanah R; Alt EU; Braun SE
    CRISPR J; 2021 Feb; 4(1):92-103. PubMed ID: 33616448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-viral and viral delivery systems for CRISPR-Cas9 technology in the biomedical field.
    He ZY; Men K; Qin Z; Yang Y; Xu T; Wei YQ
    Sci China Life Sci; 2017 May; 60(5):458-467. PubMed ID: 28527117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel sgRNA selection system for CRISPR-Cas9 in mammalian cells.
    Zhang H; Zhang X; Fan C; Xie Q; Xu C; Zhao Q; Liu Y; Wu X; Zhang H
    Biochem Biophys Res Commun; 2016 Mar; 471(4):528-32. PubMed ID: 26879140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delivering SaCas9 mRNA by lentivirus-like bionanoparticles for transient expression and efficient genome editing.
    Lu B; Javidi-Parsijani P; Makani V; Mehraein-Ghomi F; Sarhan WM; Sun D; Yoo KW; Atala ZP; Lyu P; Atala A
    Nucleic Acids Res; 2019 May; 47(8):e44. PubMed ID: 30759231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.